TNF-α MEDIATED SECRETORY COMPONENT IS POSITIVELY REGULATED BY PI3K/AKT/MTOR IN CACO-2 CELLS

被引:2
|
作者
Liu, Dongyan [1 ,2 ]
Wang, Si
Jiang, Teng
Ding, Peng
机构
[1] China Med Univ, Affiliated Shengjing Hosp, Res Ctr, Shenyang 110004, Liaoning Provin, Peoples R China
[2] China Med Univ, Minist Hlth, Key Lab Congenital Malformat Res, Shenyang 110004, Liaoning Provin, Peoples R China
基金
中国国家自然科学基金;
关键词
secretory component; polymeric Ig receptor; tumour necrosis factor-alpha; phosphoinositide; 3-kinase; mammalian target of rapamycin; POLYMERIC IMMUNOGLOBULIN RECEPTOR; ENTEROTOXIGENIC ESCHERICHIA-COLI; IG RECEPTOR; EXPRESSION; BINDING; PROTEIN; TRANSCYTOSIS; LACTOFERRIN; LINE;
D O I
10.2478/jomb-2013-0008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Secretory component (SC) is the extracellular component of the polymeric immunoglobulin receptor (pIgR) that functions as a receptor for externally secreted polymeric immunoglobulins such as secretory IgA. SC expression is regulated by a signaling pathway involving TNF-alpha. Methods: Caco-2 cells were cotreated with TNF-alpha plus either Wortmannin, which inhibits PI3K, or Rapamycin, which inhibits mTOR. The expression of SC and pIgR mRNA were assessed by immunocytochemistry, Western blotting, and Quantitative real-time PCR. Results: Wortmannin and Rapamycin decreased the fraction of cells expressing SC, as well as the total expression of SC protein and pIgR mRNA. Conclusions: TNF-alpha regulation of SC expression is mediated through a PI3K/AKT/mTOR signaling pathway in Caco-2 cells.
引用
收藏
页码:116 / 120
页数:5
相关论文
共 50 条
  • [41] PirB inhibits axonal outgrowth via the PI3K/Akt/mTOR signaling pathway
    Bi, Yong-Yan
    Quan, Yong
    MOLECULAR MEDICINE REPORTS, 2018, 17 (01) : 1093 - 1098
  • [42] The PI3K/Akt/mTOR pathway is activated in murine lupus nephritis and downregulated by rapamycin
    Stylianou, Kostas
    Petrakis, Ioannis
    Mavroeidi, Vasiliki
    Stratakis, Stavros
    Vardaki, Eleftheria
    Perakis, Kostas
    Stratigis, Spyros
    Passam, Andreas
    Papadogiorgaki, Eva
    Giannakakis, Kostas
    Nakopoulou, Lydia
    Daphnis, Eugene
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (02) : 498 - 508
  • [43] Deciphering the Role of PI3K/Akt/mTOR Pathway in Breast Cancer Biology and Pathogenesis
    McAuliffe, Priscilla F.
    Meric-Bernstam, Funda
    Mills, Gordon B.
    Gonzalez-Angulo, Ana M.
    CLINICAL BREAST CANCER, 2010, 10 : S59 - S65
  • [44] Tamoxifen ameliorates obstructive nephropathy through Src and the PI3K/Akt/mTOR pathway
    Kim, Chang Seong
    Kim, In Jin
    Choi, Joon Seok
    Bae, Eun Hui
    Ma, Seong Kwon
    Kim, Soo Wan
    BIOLOGY OF THE CELL, 2019, 111 (01) : 18 - 27
  • [45] HBx induces HepG-2 cells autophagy through PI3K/Akt-mTOR pathway
    Wang, Peng
    Guo, Qing-song
    Wang, Zhi-wei
    Qian, Hai-xin
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2013, 372 (1-2) : 161 - 168
  • [46] The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer
    Slomovitz, Brian M.
    Coleman, Robert L.
    CLINICAL CANCER RESEARCH, 2012, 18 (21) : 5856 - 5864
  • [47] The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism
    Tian, Ling-Yu
    Smit, Daniel J.
    Juecker, Manfred
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [48] PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond
    Fattahi, Sadegh
    Amjadi-Moheb, Fatemeh
    Tabaripour, Reza
    Ashrafi, Gholam Hossein
    Akhavan-Niaki, Haleh
    LIFE SCIENCES, 2020, 262
  • [49] Fisetin Inhibits Autophagy in HepG2 Cells via PI3K/Akt/mTOR and AMPK Pathway
    Sundarraj, Kiruthika
    Raghunath, Azhwar
    Panneerselvam, Lakshmikanthan
    Perumal, Ekambaram
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2021, 73 (11-12): : 2502 - 2514
  • [50] Association of BAFF with PI3K/Akt/mTOR signaling in lupus nephritis
    Ge, Fengmei
    Wang, Fangfang
    Yan, Xiuqing
    Li, Zhao
    Wang, Xuebin
    MOLECULAR MEDICINE REPORTS, 2017, 16 (05) : 5793 - 5798